Vancomycin-resistant enterococcus colonization and infection in children: Six-year follow-up

Turkish Journal of Pediatrics

Volumn 56, Issue 6, 2014, Pages 618-625

  Özkaya Parlakay, Aslınur ^a   Cengiz, Ali Bülent ^a   Ceyhan, Mehmet ^a   Bağdat, Arzu ^a   Barin Kurtoglu C ^a   Gürbüz, Venhar ^a   Aycan, Ahmet Emre ^a   Kara, Ateş ^a  

^a Sect Infect Dis Hacettepe U   (Turkey)

Author keywords

Colonization; Infection; Vancomycin resistant enterococcus

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEPHALOSPORIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; CHILD; ENTEROCOCCUS AVIUM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS HIRAE; ENTEROCOCCUS SOLITARIUS; FECES ANALYSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEDIATRICS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEPSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS INFECTION; ADOLESCENT; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; INFANT; ISOLATION AND PURIFICATION; LENGTH OF STAY; MICROBIOLOGY; NEWBORN; RISK FACTOR; TIME FACTOR; TRENDS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; ENTEROCOCCUS; FEMALE; FOLLOW-UP STUDIES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; RISK FACTORS; TIME FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84941197782     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci [letter]. Lancet 1988; 1: 57-58.
2. Zirakzadeh A, Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 2006; 81: 529-536.
3. Chavers LS, Moser SA, Funkhouser E, et al. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci. Microb Drug Resist 2003; 9: S69-S77.
4. Haas EJ, Zaoutis TE, Prasad P, Li M, Coffin SE. Risk factors and outcomes for vancomycin-resistant Enterococcus bloodstream infection in children. Infect Control Hosp Epidemiol 2010; 31: 1038-1042.
5. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342: 710-721.
6. English BK, Shenep JL. Enterococcal and viridans streptococcal infections. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL (eds). Textbook of Pediatric Infectious Diseases (5th ed). Philadelphia, PA: WB Saunders; 2004: 1175-1203.
7. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29: 996-1011.
8. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32: S133-S145.
9. Barisić Z, Punda-Polić V. Antibiotic resistance among enterococcal strains isolated from clinical specimens. Int J Antimicrob Agents 2000; 16, 65-68.
10. Ozkuyumcu C. Resistant enterococci: prevalence and factors associated with colonization in a Turkish university hospital. Acta Microbiol Pol 1999; 48: 203-207.
11. Reinert RR, Conrads G, Schlaeger JJ, et al. Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany. J Clin Microbiol 1999; 37: 1638-1641.
12. Bouchillon SK, Johnson BM, Hoban DJ, et al. Determining incidence of extended spectrum betalactamase producing Enterobacteriaceae, vancomycinresistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 2004; 24: 119-124.
13. Inan A, Ozgultekin A, Akcay SS, et al. Alterations in bacterial spectrum and increasing resistance rates in isolated microorganisms from device-associated infections in an intensive care unit of a teaching hospital in Istanbul (2004-2010). Jpn J Infect Dis 2012; 65: 146-151.
14. Altun B, Cengiz AB, Kara A, et al. First vancomycinresistant blood isolate of Enterococcus faecium in a children’s hospital and molecular analysis of the mechanism of resistance. Turk J Pediatr 2008; 50: 554-558.
15. Domig KJ, Mayer HK, Kneifel W. Methods used for the isolation, enumeration, characterisation and identification of Enterococcus spp. 1. Media for isolation and enumeration. Int J Food Microbiol 2003; 88: 147-164.
16. Domig KJ, Mayer HK, Kneifel W. Methods used for the isolation, enumeration, characterisation and identification of Enterococcus spp. 2. Pheno-and genotypic criteria. Int J Food Microbiol 2003; 88: 165-188.
17. Lee WG, Park IJ, Jin HY, Park MH. Relapse and reacquisition of rectal colonization by vancomycinresistant Enterococcus faecium after decolonization. Epidemiol Infect 2010; 138: 1449-1453.
18. Martone WJ. Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998; 19: 539-545.
19. Byers KE, Anglim AM, Anneski CJ, Farr BM. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002; 23: 207-211.
20. Bossaer JB, Hall PD, Garrett-Mayer E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2010; 19: 231-237.
21. Zaas AK, Song X, Tucker P, Perl TM. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002; 35: 1139-1146.
22. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996; 22: 663-670.
23. McKinnell JA, Kunz DF, Chamot E, et al. Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol 2012; 33: 718-724.
24. de Bruin MA, Riley LW. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis 2007; 7: 24.
25. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycosideresistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1363-1367.
26. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycinresistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-1133.
27. Nguyen GC, Leung W, Weizman AV. Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States. Inflamm Bowel Dis 2011; 17: 1338-1342.
28. Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect 2012; 18: 388-394.
29. Furuno JP, McGregor JC, Harris AD, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006; 166: 580-585.
30. Hayakawa K, Marchaim D, Martin ET, et al. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia. Antimicrob Agents Chemother 2012; 56: 2452-2458.
31. Han SH, Chin BS, Lee HS, et al. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome. J Infect 2009; 58: 182-190.
32. Sakka V, Tsiodras S, Galani L, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect 2008; 14: 14-21.
33. Reduction of Nosocomial Vancomycin-Resistant Enterococci (VRE) Colonization and Infection by Active Surveillance and Intervention of Infection Control. http://clinicaltrials.gov/show/NCT01201031. Accessed in Jun 2013.